Reports - Oxygen Therapy Equipment Market
Oxygen Therapy Equipment Market Size Analysis Report 2025-2035 by Product (Oxygen Source Equipment, Oxygen Delivery Devices) by Portability (Standalone Devices, Portable Devices) by Application (Asthma, Obstructive Sleep Apnea, COPD, Respiratory Distress Syndrome, Others) by Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Industry Leaders Trust Us For Actionable Intelligence
USD 3.8 Billion
USD 6.9 Billion
7.7%
North America
Asia Pacific
2024
2021 - 2023
2025 - 2035
By Product, By Portability, By Application, By Region
The final deliverable will encompass both quantitative and qualitative data, providing a comprehensive analysis of the market. The scope is customizable.
The global Oxygen Therapy Equipment Market is valued at USD 3.8 Billion in 2024 and is projected to reach a value of USD 6.9 Billion by 2035 at a CAGR (Compound Annual Growth Rate) of 7.7% between 2025 and 2035.
Oxygen therapy is a medical treatment designed for individuals who struggle to get adequate oxygen into their bodies. Since oxygen is essential for cellular metabolism and tissue oxygenation is vital for maintaining proper physiological functions, this therapy provides oxygen gas to support both acute and chronic patient care. Oxygen therapy equipment plays a significant role in managing various respiratory conditions such as chronic obstructive pulmonary disease (COPD), asthma, and respiratory distress.
The Oxygen Therapy Equipment market is driven by the prevalence of chronic respiratory diseases, technological advancement, and shifts toward home care. With portable oxygen concentrators, advanced masks, and high-flow nasal cannulas, patients are finding comfort and ease in access to a new level of care. Advancements in medical device technology and growing investments in medical R&D are also estimated to create new opportunities for Oxygen Therapy Equipment market going forward. However, high costs of oxygen therapy equipment and lack of favorable reimbursement policies are forecasted to restrain Oxygen Therapy Equipment market development in the future.
The product segment is divided into oxygen source equipment, and oxygen delivery devices. Oxygen source equipment is divided into oxygen concentrator, liquid oxygen devices, and oxygen cylinders. The oxygen source equipment segment held the largest share of 54.30% in the Oxygen Therapy Equipment market.
The oxygen source equipment segment in the Oxygen Therapy Equipment market encompasses oxygen concentrators, liquid oxygen devices, and oxygen cylinders, each catering to distinct patient needs. The segments growth is driven by the increasing prevalence of respiratory diseases, an aging population, advances in technology, and the shift towards home healthcare, with portable solutions leading the market due to their mobility and user-friendly features.
Oxygen concentrators, available as stationary or portable units, extract oxygen from ambient air and are favored for their convenience, particularly portable models, which have gained popularity due to rising respiratory disorders like COPD. Liquid oxygen devices store oxygen in a compact, cryogenic form, offering high-capacity storage and a consistent flow, making them ideal for hospital or long-term care use, though they require specialized handling. Oxygen cylinders, the traditional method for oxygen delivery, provide compressed gas for emergency or backup needs but are less portable and require frequent refills.
The portability segment is divided into stationary devices, and portable devices. The stationary devices segment held the largest share of 70.20% in the Oxygen Therapy Equipment market.
The stationary devices include all large concentrators and high-capacity systems, hence dominating healthcare facilities and long-term care settings. They are majorly important for offering high-flow oxygen therapy, especially to patients who either suffer from severe respiratory conditions or receive continuous therapy.
The prevalent chronic respiratory diseases along with patient care stability rank as the chief driving forces for these reliable and consistent devices, making them a crucial for the market. Advancements in the Oxygen Therapy Equipment market of stationary devices such as efficiency improvements in filtration systems, alarms that are automated, and energy-efficient designs will enhance operational effectiveness as well as patient comfort. The prevalent chronic respiratory diseases along with patient care stability rank as the chief driving forces for these reliable and consistent devices, making them a staple of the market.
Portable oxygen devices have become an essential part of the oxygen therapy market, providing mobility, flexibility, and independence for patients. The segment in the Oxygen Therapy Equipment market focuses on lightweight, compact, and mobile solutions designed to provide respiratory support for patients on the go. The portable devices is driven by rise in demand for portable devices has been fueled by the increasing prevalence of respiratory diseases, the aging population, and heightened awareness about oxygen therapys benefits. Portable oxygen concentrators (POCs) are the cornerstone of this segment, offering the ability to extract and deliver oxygen from ambient air in a user-friendly and battery-powered format. These devices are particularly favored for their convenience, allowing patients to maintain an active lifestyle while receiving oxygen therapy.
The application segment is divided into Asthma, obstructive sleep apnea, COPD, Respiratory distress syndrome, and others. The COPD segment held the largest share of 28.70% in the Oxygen Therapy Equipment market.
COPD becomes more widespread, and growing demand for effective respiratory support, including oxygen therapy equipment, surges, contributing significantly to market growth. Technological advancement and innovation in oxygen delivery systems, offering more efficient and user-friendly solution are also supporting market. The increasing awareness among healthcare providers and patients about the benefits of early and continuous oxygen therapy has significantly impacted Oxygen Therapy Equipment market revenue growth.
In 2024, the North America captured largest revenue share of 40.20%.
North America Oxygen Therapy Equipment market is driven by rising portability of medical devices is a major factor driving revenue growth of the market in this region. Portable oxygen concentrators, stationary concentrators, and other oxygen therapy devices have become integral in maintaining various respiratory ailments. Home healthcare settings are witnessing an increasing adoption of these devices, promoting patient comfort and adherence to prescribed oxygen levels.
Technological advancements in oxygen delivery systems, including enhanced portability and user-friendly interfaces, contribute to the ever-rising demand. The expanding home healthcare market and a proactive approach to respiratory health maintenance is further expected to boost product adoption. As North America focuses on improving healthcare infrastructure, demand for oxygen therapy equipment is expected to persist, addressing the evolving respiratory care needs of the region’s population.
The U.S. Oxygen Therapy Equipment market is significantly influenced by the integration of telehealth services. The COVID-19 pandemic has accelerated the adoption of telehealth solutions, including remote monitoring and virtual consultations, which continue to reshape the landscape of oxygen therapy. Through telehealth, real-time monitoring of patients' oxygen levels is made possible, allowing for timely adjustments to treatment plans and improving both patient outcomes and adherence to prescribed therapies. Major healthcare providers and insurance companies in the U.S. have increasingly incorporated telehealth into their offerings, integrating it with home oxygen therapy services.
The European Oxygen Therapy Equipment market is expected to account for a substantial share driven by the increasing integration of telehealth solutions into healthcare systems. The adoption of telehealth has been accelerated by the COVID-19 pandemic, promoting innovations like remote oxygen level monitoring and virtual consultations. These advancements enable healthcare providers to tailor treatment plans more effectively, improving patient outcomes and adherence to oxygen therapy regimens. Many European countries have embraced telehealth as part of their healthcare strategies, often in conjunction with home oxygen therapy programs.
The Germany Oxygen Therapy Equipment market is driven by advanced healthcare infrastructure and strong focus on digitalization have made telehealth integration particularly effective, especially when combined with home oxygen therapy services. These synergies improve patient management and extend access to oxygen therapy for individuals in rural and underserved areas. Additionally, the rising prevalence of chronic respiratory conditions such as COPD and the countrys emphasis on early intervention and preventative care are key factors driving Oxygen Therapy Equipment market expansion.
Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point
Rise in the prevalence of respiratory diseases
The growth of the Oxygen Therapy Equipment market is driven by the rising prevalence of respiratory diseases, which remains a key factor fueling demand. The expanding geriatric population, more prone to chronic respiratory conditions, also plays a significant role in market expansion. Additionally, the increasing preference for home-based oxygen therapy and continuous advancements in technology are accelerating Oxygen Therapy Equipment market growth. The shift from traditional oxygen cylinders to portable concentrators is another notable trend, contributing to the market’s upward trajectory. Furthermore, early detection of respiratory disorders and the increasing prevalence of tobacco smoking are influencing market further boosting the adoption of Oxygen Therapy Equipment market.
High Cost of Oxygen Concentrators
The growth of the Oxygen Therapy Equipment market is obstructed by the high cost of oxygen concentrators, along with potential side effects such as nasal dryness and skin irritation from prolonged use, can limit the widespread adoption of these devices. Additionally, stringent regulatory requirements and delays in product approvals pose significant hurdles for manufacturers. The availability of low-cost alternatives from local manufacturers, coupled with cuts in Medicare reimbursement rates for home oxygen therapy, further restrain Oxygen Therapy Equipment market growth by making it more difficult for certain patients to afford these treatments. These factors together present notable obstacles to the expansion of the Oxygen Therapy Equipment market.
The Oxygen Therapy Equipment market is characterized by the presence of both established players and emerging companies, each strive for market share through product innovation, strategic partnerships, and geographic expansion. Industry giants like Philips Healthcare, Linde Healthcare, Invacare Corporation, Becton, Dickinson and Company, Teleflex Incorporated, Smiths Medical, Essex Industries, GCE Holdings Inc, Messer Meducal Austria GmbH, Medicap Homecare GmbH. These companies maintain a strong market presence through a wide range of products, established distribution networks, and significant investments in innovation. Technological advancements, such as portable oxygen concentrators with improved battery life and stationary devices featuring energy-efficient designs and smart connectivity, are key differentiators.
The key players in the global Oxygen Therapy Equipment market include - Philips Healthcare among others.
Emerson Introduces Healthcare Industry’s First Integrated Manifold Solution for Respiratory Therapy Devices
Inogen Achieves Regulatory Milestones to Support Current and Future Products
The global Oxygen Therapy Equipment market can be categorized as Product, Portability, Application and Region.
| Parameter | Details |
|---|---|
| Segment Covered | By Product
By Portability
By Application
By Region
|
| Companies Covered |
|
| Customization Scope | Enjoy complimentary report customization—equivalent to up to 8 analyst working days—with your purchase. Customizations may include additions or modifications to country, regional, or segment-level data. |
| Pricing and purchase options | Access flexible purchase options tailored to your specific research requirements. Explore purchase options |
Key features include:
Contact
Toll Free Number+1 (877) 462-2282